Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has provided an update.
Proteomics International Laboratories Ltd. has announced a Share Purchase Plan following a successful placement of shares to sophisticated and institutional investors, raising approximately $4 million. The funds will be used to launch Promarker tests in Australia and the USA, upgrade systems for clinical diagnostics, and establish laboratory platforms, with the total expected proceeds reaching $5.5 million. The plan offers eligible shareholders the opportunity to purchase additional shares at a discounted price, with the potential to raise an additional $1 million.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd. operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests. The company is known for its Promarker series of diagnostic tests, which are aimed at providing clinical solutions in various markets, including Australia and the USA.
YTD Price Performance: -52.50%
Average Trading Volume: 126,640
Technical Sentiment Signal: Buy
Current Market Cap: A$53.89M
See more insights into PIQ stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue